Product
VXX-401
1 clinical trial
1 indication
Indication
HypercholesterolemiaClinical trial
A Phase 1, First-in-Human, Dose Escalation Study to Evaluate the Safety, Tolerability, Immunogenicity, and Pharmacodynamics of VXX-401 in Healthy AdultsStatus: Active (not recruiting), Estimated PCD: 2024-06-27